Hoosier Drug Company Asks U.S. Gov. to Allow Emergency Use
Thursday, October 8, 2020

Hoosier drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, as well as hospitalizations and ER visits for patients with mild or moderate COVID-19.

Eli Lilly and Company announced the partial results Wednesday in a news release. Their findings have not yet been published or reviewed by independent scientists.

The drug is reportedly similar to one that President Donald Trump received late last week from a different company.


>> News Archive